PAVmed Inc.

PAVM Nasdaq SEC CIK 1624326
Follow PAVmed Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $41K +720% vs same quarter last year
Net income −$11.7M −116.5% vs same quarter last year
EPS, diluted −$1.77 −510.3% vs same quarter last year
Operating cash flow $2.4M +369.5% vs same quarter last year
Revenue by quarter
$10K
$8K
$6K
$5K
$52K
$22K
$33K
$41K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income12 fiscal years
  • Revenue
  • Net income
−$100M−$50M$0$50MFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$71K−$3.8M
FY24$3M$32M
FY23$2.5M−$66.3M
FY22$377K−$89M
FY21$500K−$50.3M
FY20-−$34.3M
FY19-−$16.5M
FY18-−$18M
FY17-−$9.5M
FY16-−$5.7M
FY15-−$1.8M
FY14--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−40000%−30000%−20000%−10000%0%10000%FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-−30712.7%−5315.5%
FY24−61.6%−1485.4%1067.3%
FY23−161.8%−2805.7%−2702.7%
FY22-−24161%−23602.9%
FY21−17%−10878.6%−10069.4%
FY20---
FY19---
FY18---
FY17---
FY16---
FY15---
FY14---
Free cash flowOperating cash flow minus capital expenditure
−$80M−$60M−$40M−$20M$0FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$5.2M
FY24−$33.6M
FY23−$52.3M
FY22−$72.5M
FY21−$42.1M
FY20−$22M
FY19−$13.4M
FY18−$8.8M
FY17−$6.6M
FY16−$4.5M
FY15-
FY14-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • PAVmed
  • Healthcare median
−30000%−20000%−10000%0%10000%FY15FY17FY19FY21FY23FY25
Show the numbers
YearPAVmedHealthcare median
FY25−5315.5%−30.6%
FY241067.3%−47%
FY23−2702.7%−58%
FY22−23602.9%−80.4%
FY21−10069.4%−71.8%
FY20-−62.2%
FY19-−46.2%
FY18-−49.6%
FY17-−45.9%
FY16-−36%
FY15-−37.8%
FY14-−35.5%